Clinical Trial Update: A Study to Evaluate Efficacy, Safety and Tolerability of Hydroxychloroquine in Subjects With Parkinson's Disease [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating hydroxychloroquine for efficacy, safety, and tolerability in Parkinson's disease, currently not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Parkinson&Amp;#39;s Disease | Phase 2 | Status: NOT_YET_RECRUITING